Published May 26, 2011 | Version v1
Journal article Open

Identification, Replication, and Functional Fine-Mapping of Expression Quantitative Trait Loci in Primary Human Liver Tissue

Description

The discovery of expression quantitative trait loci ("eQTLs") can help to unravel genetic contributions to complex traits. We identified genetic determinants of human liver gene expression variation using two independent collections of primary tissue profiled with Agilent (n = 206) and Illumina (n = 60) expression arrays and Illumina SNP genotyping (550K), and we also incorporated data from a published study (n = 266). We found that ∼30% of SNP-expression correlations in one study failed to replicate in either of the others, even at thresholds yielding high reproducibility in simulations, and we quantified numerous factors affecting reproducibility. Our data suggest that drug exposure, clinical descriptors, and unknown factors associated with tissue ascertainment and analysis have substantial effects on gene expression and that controlling for hidden confounding variables significantly increases replication rate. Furthermore, we found that reproducible eQTL SNPs were heavily enriched near gene starts and ends, and subsequently resequenced the promoters and 3′UTRs for 14 genes and tested the identified haplotypes using luciferase assays. For three genes, significant haplotype-specific in vitro functional differences correlated directly with expression levels, suggesting that many bona fide eQTLs result from functional variants that can be mechanistically isolated in a high-throughput fashion. Finally, given our study design, we were able to discover and validate hundreds of liver eQTLs. Many of these relate directly to complex traits for which liver-specific analyses are likely to be relevant, and we identified dozens of potential connections with disease-associated loci. These included previously characterized eQTL contributors to diabetes, drug response, and lipid levels, and they suggest novel candidates such as a role for NOD2 expression in leprosy risk and C2orf43 in prostate cancer. In general, the work presented here will be valuable for future efforts to precisely identify and functionally characterize genetic contributions to a variety of complex traits.

Files

journal.pgen.1002078.pdf

Files (22.4 MB)

Name Size Download all
Article
md5:63cf58c7de5212eb4852a57bd30b40d3
15.7 MB Preview Download
md5:985ad26b9ed64b5d8f5d3f450626b291
6.7 MB Preview Download

Additional details

Identifiers

DOI
10.1371/journal.pgen.1002078
Other
oai:uchicago.tind.io:10411

Funding

University of Chicago
National Institute of Diabetes and Digestive and Kidney Diseases
R21DK081157-01A2
University of Chicago
Cancer Research Center Grant
National Cancer Institute
K07CA140390-01
Pharmacogenetics of Anticancer Agents Research
National Institute of General Medical Sciences
U01 GM61393
National Institutes of Health
U01 HL66682
National Institutes of Health
NS053646
National Institute of General Medical Sciences
P01 GM32165
National Institutes of Health
R01GM094418
National Institutes of Health
N01-DK-7-0004/HHSN267200700004C
Cooperative Human Tissue Network
National Center for Research Resources
1KL2RR025015
Lilly-Life Sciences Research Foundation
Fellowship
Jane Coffin Childs Memorial Fund
Postdoctoral Fellowship

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Clinical Pharmacology and Pharmacogenomics, Ecology and Evolution, Medicine
Center(s) or Institute(s)
Institute for Genomics and Systems Biology